

Oxford Immunotec is engaged in developing and commercializing proprietary tests for the management of immune-regulated conditions. Among its major competitors, Oxford Immunotec Global PLC is ranked in 4th place for NPS while Sanofi Pasteur is 1st, and Illumina is 2nd.Their current market cap is $570.90M